Acquired Factor V Inhibitor Presenting as a Spontaneous Intramuscular Haematoma in a 95-Year-Old Man With Evidence of Immune Dysregulation: A Case Report

Acquired factor V deficiency (AFVD) is a rare, acquired bleeding disorder caused by the development of inhibitors against coagulation factor V. It most commonly occurs following exposure to bovine thrombin, surgery, infections, antibiotics, autoimmune disease or malignancy, although a proportion of cases remain idiopathic. Clinical presentation is variable and ranges from incidental coagulation abnormalities to life-threatening haemorrhage. Owing to its rarity, diagnosis requires a high index of suspicion. This case presents a 95-year-old man who came in with acute left thigh pain and swelling without preceding trauma. Imaging demonstrated a large spontaneous intramuscular haematoma involving the anterior compartment of the thigh with evidence of active contrast extravasation. Laboratory investigations showed marked prolongation of both the prothrombin time (PT) and activated partial thromboplastin time (APTT). Mixing studies demonstrated incomplete correction, and coagulation factor assays identified isolated severe factor V deficiency (5 IU/dL). Finding a factor V inhibitor titre of 0.8 Bethesda units (BU) was strongly suggestive of an acquired inhibitor. Further investigations demonstrated a positive direct antiglobulin test (DAT) (IgG 3+), positive lupus anticoagulant and polyclonal hypergammaglobulinemia, although extensive autoimmune and malignancy screening was otherwise unremarkable. He was managed conservatively with fresh frozen plasma (FFP), tranexamic acid, corticosteroids and intravenous immunoglobulin (IVIG). The haematoma showed clinical improvement without further documented expansion; however, coagulation parameters fluctuated and remained markedly prolonged at the final assessment. Repeat factor V activity and inhibitor titres were unavailable, so inhibitor eradication could not be confirmed. His admission was subsequently complicated by hospital-acquired pneumonia and SARS-CoV-2 infection, resulting in progressive respiratory failure and death.

Authors

Publication Details

Journal
Cureus
Published
2026-11-21
DOI
https://doi.org/10.7759/cureus.120054
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Acquired Factor V Inhibitor Presenting as a Spontaneous Intramuscular Haematoma in a 95-Year-Old Man With Evidence of Immune Dysregulation: A Case Report

Khine Oo Mon, Laurel A. Williams, Thi Thi Nay Linn
Cureus
Hemophilia Treatment and Research
article

Acquired Factor V Inhibitor Presenting as a Spontaneous Intramuscular Haematoma in a 95-Year-Old Man With Evidence of Immune Dysregulation: A Case Report

Khine Oo Mon, Laurel A. Williams, Thi Thi Nay Linn
article en

Abstract

Acquired factor V deficiency (AFVD) is a rare, acquired bleeding disorder caused by the development of inhibitors against coagulation factor V. It most commonly occurs following exposure to bovine thrombin, surgery, infections, antibiotics, autoimmune disease or malignancy, although a proportion of cases remain idiopathic. Clinical presentation is variable and ranges from incidental coagulation abnormalities to life-threatening haemorrhage. Owing to its rarity, diagnosis requires a high index of suspicion. This case presents a 95-year-old man who came in with acute left thigh pain and swelling without preceding trauma. Imaging demonstrated a large spontaneous intramuscular haematoma involving the anterior compartment of the thigh with evidence of active contrast extravasation. Laboratory investigations showed marked prolongation of both the prothrombin time (PT) and activated partial thromboplastin time (APTT). Mixing studies demonstrated incomplete correction, and coagulation factor assays identified isolated severe factor V deficiency (5 IU/dL). Finding a factor V inhibitor titre of 0.8 Bethesda units (BU) was strongly suggestive of an acquired inhibitor. Further investigations demonstrated a positive direct antiglobulin test (DAT) (IgG 3+), positive lupus anticoagulant and polyclonal hypergammaglobulinemia, although extensive autoimmune and malignancy screening was otherwise unremarkable. He was managed conservatively with fresh frozen plasma (FFP), tranexamic acid, corticosteroids and intravenous immunoglobulin (IVIG). The haematoma showed clinical improvement without further documented expansion; however, coagulation parameters fluctuated and remained markedly prolonged at the final assessment. Repeat factor V activity and inhibitor titres were unavailable, so inhibitor eradication could not be confirmed. His admission was subsequently complicated by hospital-acquired pneumonia and SARS-CoV-2 infection, resulting in progressive respiratory failure and death.

Cureus
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Acquired Factor V Inhibitor Presenting as a Spontaneous Intramuscular Haematoma in a 95-Year-Old Man With Evidence of Immune Dysregulation: A Case Report — Khine Oo Mon, Laurel A. Williams, et al. · Cureus (2026) | TGRS Research Map | TGRS